Persistent Staphylococcus aureus bacteremia: incidence and outcome trends over time.
about
Characterization of methicillin-resistant Staphylococcus aureus isolates from patients with persistent or recurrent bacteremia.Waves of resistance: Staphylococcus aureus in the antibiotic era.Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.Telavancin, a new lipoglycopeptide antimicrobial, in complicated skin and soft tissue infectionsEffect of statin therapy in the outcome of bloodstream infections due to Staphylococcus aureus: a prospective cohort studyAssociation of mannose-binding lectin 2 gene polymorphisms with persistent Staphylococcus aureus bacteremia.Persistent Staphylococcus aureus bacteremia: a prospective analysis of risk factors, outcomes, and microbiologic and genotypic characteristics of isolates.Community-associated meticillin-resistant Staphylococcus aureusAdjunctive rifampicin to reduce early mortality from Staphylococcus aureus bacteraemia (ARREST): study protocol for a randomised controlled trial.Accessory gene regulator (agr) dysfunction in Staphylococcus aureus bloodstream isolates from South Korean patients.Predictors and clinical outcomes of persistent methicillin-resistant Staphylococcus aureus bacteremia: a prospective observational study.agr Dysfunction and persistent methicillin-resistant Staphylococcus aureus bacteremia in patients with removed eradicable foci.Skin and soft-tissue infections: a critical review and the role of telavancin in their treatment.When sepsis persists: a review of MRSA bacteraemia salvage therapy.Phenotypic changes of methicillin-resistant Staphylococcus aureus during vancomycin therapy for persistent bacteraemia and related clinical outcome.Epidemiology of Methicillin-Resistant Staphylococcus aureus Bacteremia in Children.Persistent Staphylococcus aureus isolates from two independent cases of bacteremia display increased bacterial fitness and novel immune evasion phenotypes.Vancomycin MIC plus heteroresistance and outcome of methicillin-resistant Staphylococcus aureus bacteremia: trends over 11 years.Managing Severe Community-Acquired Pneumonia Due to Community Methicillin-Resistant Staphylococcus aureus (MRSA).Staphylococcus aureus bacteraemia and endocarditis - epidemiology and outcome: a review.Strategies against methicillin-resistant Staphylococcus aureus persisters.Antibiotic Choice May Not Explain Poorer Outcomes in Patients With Staphylococcus aureus Bacteremia and High Vancomycin Minimum Inhibitory Concentrations
P2860
Q33640218-A39B613C-7477-43DB-81AA-4C7B85081431Q33854398-7A8C4957-C5B3-427E-A364-235BD2C8B8B1Q34478074-5D9F6EFB-F524-4376-80E0-1E0F06D7A8CBQ35026607-71802EF0-4337-4CE1-9ACC-E8C711C5FD26Q35077842-9DB58BD9-BEBB-47EA-8FC5-BA74042CD69DQ35111021-61E443D1-0913-443B-A689-1F286768AC3CQ36008997-4B19975E-3664-4430-B779-0BB6BB7A2BA9Q36438720-DF2635E2-26A3-490B-B522-B17FA6E68FF9Q36568337-40D24360-CB1D-41E1-A69E-8955B78E52DBQ36667182-6E72383C-3173-4DEE-AE29-612E420A3E38Q37356506-8B67B268-8459-4230-B30C-05AF0921578BQ38457418-D21C7305-2A49-4C7B-9F33-BBBC7A9D510FQ38575717-DEB20CFB-8878-479C-8932-6686AF129B50Q38632488-1ED8F8BF-7B2F-4A36-9810-E9111A388513Q38880547-941FDECE-0385-4DD1-A6E2-4024FAD0EF6FQ39340850-97AA3C65-ECB6-4B2F-A223-9601B18E0025Q40855979-2C4F1FA4-7B0C-41F9-8717-F51EEF82E8CDQ43117809-F637261D-855E-41A4-8575-C3DEE2FD86AFQ43636170-C0798B6D-CACF-4705-B351-F3504B0D9B63Q47654030-0D7CB4EC-F6A4-4C9C-A5FF-B1F6884437D0Q52640792-F1C5A044-9983-4C84-A9E9-CCF50EB5541FQ57763234-4E983D51-DD90-4192-9303-566FDCA8815C
P2860
Persistent Staphylococcus aureus bacteremia: incidence and outcome trends over time.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Persistent Staphylococcus aureus bacteremia: incidence and outcome trends over time.
@en
Persistent Staphylococcus aureus bacteremia: incidence and outcome trends over time.
@nl
type
label
Persistent Staphylococcus aureus bacteremia: incidence and outcome trends over time.
@en
Persistent Staphylococcus aureus bacteremia: incidence and outcome trends over time.
@nl
prefLabel
Persistent Staphylococcus aureus bacteremia: incidence and outcome trends over time.
@en
Persistent Staphylococcus aureus bacteremia: incidence and outcome trends over time.
@nl
P2093
P2860
P1476
Persistent Staphylococcus aureus bacteremia: incidence and outcome trends over time.
@en
P2093
P2860
P356
10.1080/00365540802441711
P577
2009-01-01T00:00:00Z